Health
Singapore develops potential antibody treatment for yellow fever – BSA bureau
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
Researchers from Antimicrobial Resistance (AMR), an interdisciplinary group at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed TY014, a potential antibody treatment for yellow fever. SMART AMR collaborated with researchers from Massachusetts Institute of Technology (MIT), and local institutions such as the Singapore Ge…
-
General15 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Noosa News21 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025
-
Business23 hours agoBell Potter names the best ASX shares to buy in October
-
General20 hours agoAustralia welcomes Gaza peace progress, hostage release